JPMORGAN CHASE & CO - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 248 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$85,083,577
-16.3%
1,694,217
+5.3%
0.01%
-18.2%
Q2 2023$101,661,561
+45.6%
1,608,569
+3.7%
0.01%
+22.2%
Q1 2023$69,813,495
+109936.1%
1,551,756
+7.1%
0.01%
+12.5%
Q4 2022$63,446
-99.9%
1,448,215
-2.8%
0.01%
-42.9%
Q3 2022$98,219,000
+12.8%
1,490,634
-13.6%
0.01%
+16.7%
Q2 2022$87,105,000
-18.6%
1,724,490
+2.9%
0.01%
-7.7%
Q1 2022$107,006,000
-39.2%
1,675,124
+1.9%
0.01%
-35.0%
Q4 2021$176,106,000
+12.9%
1,644,161
+8.3%
0.02%
+5.3%
Q3 2021$156,047,000
+13.0%
1,517,811
-3.3%
0.02%
+18.8%
Q2 2021$138,088,000
-7.6%
1,569,896
+2.1%
0.02%
-20.0%
Q1 2021$149,475,000
-11.2%
1,537,343
+2.5%
0.02%
-20.0%
Q4 2020$168,253,000
+34.4%
1,500,256
+9.8%
0.02%
+19.0%
Q3 2020$125,149,000
+43.9%
1,366,712
+22.6%
0.02%
+23.5%
Q2 2020$86,956,000
+53.3%
1,114,828
+15.0%
0.02%
+30.8%
Q1 2020$56,710,000
+521.5%
969,765
+751.5%
0.01%
+550.0%
Q4 2019$9,124,000
+2.2%
113,892
-6.3%
0.00%0.0%
Q3 2019$8,931,000
-14.4%
121,558
+8.0%
0.00%0.0%
Q2 2019$10,432,000
+17.0%
112,517
+1.0%
0.00%0.0%
Q1 2019$8,915,000
+108.7%
111,374
+40.6%
0.00%
+100.0%
Q4 2018$4,272,000
-28.9%
79,222
+2.9%
0.00%0.0%
Q3 2018$6,012,000
+29.6%
77,011
+5.3%
0.00%0.0%
Q2 2018$4,640,000
-4.1%
73,107
+38.6%
0.00%0.0%
Q1 2018$4,838,000
+206.6%
52,758
+152.2%
0.00%
Q4 2017$1,578,000
+104.4%
20,915
+85.5%
0.00%
Q3 2017$772,000
+44.3%
11,276
+6.8%
0.00%
Q2 2017$535,000
-90.8%
10,559
-92.7%
0.00%
-100.0%
Q1 2017$5,788,000
+23.6%
144,725
-13.3%
0.00%0.0%
Q4 2016$4,681,000
-4.3%
166,893
+1.3%
0.00%0.0%
Q3 2016$4,892,000
+51.5%
164,725
+3.3%
0.00%0.0%
Q2 2016$3,228,000
+123.1%
159,400
+98.8%
0.00%
Q1 2016$1,447,000
-30.7%
80,175
+1.2%
0.00%
-100.0%
Q4 2015$2,088,000
+6.9%
79,250
-13.4%
0.00%0.0%
Q3 2015$1,953,000
-71.8%
91,523
-65.0%
0.00%
-50.0%
Q2 2015$6,937,000261,8500.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders